At a glance
- Originator Organon
- Class Neuroprotectants; Nootropics; Organic chemicals; Peptide fragments
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 08 Jan 2001 Discontinued-Preclinical for Cognition disorders in Netherlands (Unknown route)
- 05 Oct 1994 No-Development-Reported for Cognition disorders in Netherlands (Unknown route)